BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.33.0.1782577405//EN
X-ORIGINAL-URL:https://elephantsandtea.org/
X-WR-CALNAME:Elephants and Tea
X-WR-CALDESC:The Elephant in the Room is Cancer. Tea is the Relief Conversation Provides.
X-WR-TIMEZONE:America/New_York
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T030000
RRULE:FREQ=YEARLY;BYMONTH=03;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T010000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-117007d714adf33db6d2653d903ebf2d@elephantsandtea.org
DTSTART;TZID=America/New_York:20250820T140000
DTEND;TZID=America/New_York:20250820T150000
DTSTAMP:20250813T141204Z
CREATED:20250813
LAST-MODIFIED:20250813
PRIORITY:5
SEQUENCE:1
TRANSP:OPAQUE
SUMMARY:Navigating Communication on Clinical Trials in Oncology
DESCRIPTION:Navigating Communication on Clinical Trials in Oncology\nRegister here\nWednesday, August 20th, 2025 at 2pm ET\nClinical trials are the cornerstone of advancing cancer treatment, offering patients cutting-edge therapies while contributing to critical research. However, effective communication between patients and oncologists is essential to ensure understanding, participation, and optimal outcomes. In Cancer Nation’s 2024 State of Survivorship survey, participation in clinical trials remains consistent, with key drivers being the doctor’s recommendation (51%) and the prospect of access to new treatments (28%). Among patients who did not participate in clinical trials, 74% of patients said that they were not asked, which remains the largest barrier. Patients also cited concerns about side effects, treatment protocols, and location as secondary barriers, with these concerns being more prominent among younger patients and patients of color.\nThis webinar will discuss the role of communication in clinical trial participation. Attendees will gain insight into how communication can influence trial participation, improve patient understanding, and address concerns such as eligibility, side effects, and informed consent. Participants will also learn about resources related to clinical trial participation available to oncology professionals and their patients.\nFeatured speakers for this presentation:\n\nKristi Mitchell, MPH of Health Equity Outcomes\nDon S. Dizon, MD of Tufts University\nJoseph Unger, PhD of Fred Hutch Cancer Center\n\n
URL:https://us02web.zoom.us/webinar/register/4217405182047/WN_wSXahH66TY2EKuM973FXyw?utm_source=NCCS+Programs+and+Development&utm_campaign=abd684179d-Webinar_Clinical_Trials_Comm&utm_medium=email&utm_term=0_-e8f45b79dc-646475459&mc_cid=abd684179d&mc_eid=b4306c4d2a#/registration
ORGANIZER;CN=Cancer Nation:MAILTO:
CATEGORIES:Informative Webinars and Events
END:VEVENT
END:VCALENDAR